AI entity
Every one of those 1 sits in a single category, product-launch. National Chemical Defense Consortium is most often covered alongside AI Antidote Development Model, which appears in 1 of these 1 story. Their average consequence score of 7 runs above the beat's 6.8 for that window.
Last mentioned: Mar 19, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, product-launch. National Chemical Defense Consortium is most often covered alongside AI Antidote Development Model, which appears in 1 of these 1 story. Their average consequence score of 7 runs above the beat's 6.8 for that window. Each story carries 2 original sources on average, compared with 2.4 for the broader beat in this window. National Chemical Defense Consortium appears in 1 tracked AI story from March 19, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 36 AI stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering National Chemical Defense Consortium. Shared-story counts are live from our verified record — not editorial picks.
Lunai Bioworks has established the National Chemical Defense Consortium to bid for U.S. government contracts valued between $400 million and $1.2 billion. The initiative leverages a proprietary three-year AI model designed to radically accelerate the development of antidotes against chemical threats.
National Chemical Defense Consortium is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
